Bob T Li

40PUBLICATIONS
348CO-AUTHORS
Molecular targetsAnalytical spectrometryPredictive and prognostic markersNatural language processingCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 27, 2026
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

|Apr 16, 2025
An ultrasensitive method for detection of cell-free RNA.

Monica C Nesselbush, Bogdan A Luca, Young-Jun Jeon

|Apr 03, 2025
Diverse ERBB2/ERBB3 Activating Alterations and Coalterations Have Implications for HER2/3-Targeted Therapies across Solid Tumors.

Dazhi Liu, Justin Jee, Alexander Drilon

|Nov 20, 2024
Waiting to Exhale: The Feasibility and Appropriateness of Home Blood Oxygen Monitoring in Oncology Patients Post-Hospital Discharge.

Si-Yang Liu, Sahil D Doshi, AnnMarie Mazzella Ebstein

|Nov 07, 2024
Automated real-world data integration improves cancer outcome prediction.

Justin Jee, Christopher Fong, Karl Pichotta

|Oct 10, 2024
Clinical and Genomic Characterization of ERBB2-Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort.

Sebastián Mondaca, Henry Walch, Santiago Sepúlveda

Pageof 7

Frequent Collaborators

13 joint publications

Charles M Rudin

9 joint publications

Alexander Drilon

8 joint publications

Michael F Berger

8 joint publications

Michael Offin